Neocleus Raises $11,4 M in Series B Funding

Neocleus

Neocleus, a startup yet to release a product who recently unveiled its ‘endpoint virtualization’ strategy, seems to have been convincing enough in validating its approach to investors. The company has raised $11.4M in Series B funding (PDF) in a round led by Battery Ventures and Gemini Israel Funds, its original investors.

Neocleus applies virtualization to desktops and laptops delivering the flexibility, manageability and security needed to address different user scenarios within a dynamic, dispersed enterprise. The company’s solutions, which include a Xen-based open source Type 1 bare-metal hypervisor for endpoints, aim to enable critical IT tasks to operate in isolated, trusted virtual environments with complete access to the capabilities offered by the underlying endpoint hardware.

Neocleus was founded in 2006 by industry veterans Ariel Gorfung (CEO) and Etay Bogner (CTO) and launched last May with the announcement of the Desktop Hypervisor Framework, an endpoint hypervisor enhancement to the Xen server hypervisor that the company will be contributing to the open source community.

Most recently Neocleus announced Trusted Edge, the first in a suite of virtual software appliances that allows for secure access to corporate resources – for employees, customers and partners – regardless of the endpoint’s location or state of security.

About the author

I'm a blogger, entrepreneur, conference organizer, social media consultant, startup advisor and allround web addict, based in Belgium, Europe. I'm a writer at TechCrunch and managing editor of Virtualization.com.

Leave a Comment

Powered by WordPress | Deadline Theme : An AWESEM design